More MOUNJARO-handled individuals who designed anti-tirzepatide antibodies expert hypersensitivity reactions or injection web page reactions than people who did not produce these antibodies [see ADVERSE REACTIONS ].Tirzepatide is often a GIP receptor and GLP-one receptor agonist. It's really a 39-amino-acid modified peptide using a C20 fatty diacid